Literature DB >> 9158743

Pneumococcal resistance to beta-lactam antibiotics: a global geographic overview.

F Baquero1.   

Abstract

beta-Lactam resistance in Streptococcus pneumoniae has spread over the entire world. The 10 main foci of resistant organisms are located in the following areas: (1) southwest Europe (Spain, France, Portugal), (2) central-east Europe (Hungary, Roumania, Bulgaria, Turkey) and Israel, (3) northwest Russia, (4) South Africa, (5) Japan and South Korea, (6) Papua-New Guinea, (7) Alaska, (8) southeast North America, (9) southwest North America, and (10) south cone in South America. A comparison of the presumed factors influencing the increase of pneumococcal resistance in these foci with those occurring in low incidence areas, such as central-north Europe, Scandinavia, north and western Africa, or middle-north Mediterranean countries (Italy, Greece) should provide the clues to predict and prevent further spread of resistant pneumococci.

Entities:  

Mesh：

Year:  1995        PMID： 9158743     DOI： 10.1089/mdr.1995.1.115

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN： 1076-6294            Impact factor:   3.431


  27 in total

1.  Use of an oxacillin disk screening test for detection of penicillin- and ceftriaxone-resistant pneumococci.

Authors:  L P Jetté; C Sinave
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

2.  Lack of vancomycin tolerance in Streptococcus pneumoniae strains isolated in Barcelona, Spain, from 1999 to 2001.

Authors:  Mar Ortega; Francesc Marco; Alex Soriano; Elisa García; José A Martínez; Josep Mensa
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

3.  Comparative immune responses of patients with chronic pulmonary diseases during the 2-year period after pneumococcal vaccination.

Authors:  Meng Chen; Yuki Hisatomi; Akitsugu Furumoto; Kenji Kawakami; Hironori Masaki; Tsuyoshi Nagatake; Yoshiko Sueyasu; Tomoaki Iwanaga; Hisamichi Aizawa; Kazunori Oishi
Journal:  Clin Vaccine Immunol       Date:  2006-12-13

4.  Determination of penicillin susceptibility of Streptococcus pneumoniae using the polymerase chain reaction.

Authors:  H Jalal; S Organji; J Reynolds; D Bennett; E O'Mason; M R Millar
Journal:  Mol Pathol       Date:  1997-02

5.  In vitro activity of ceftizoxime, ceftazidime, cefuroxime, ceftriaxone, cefotaxime, and penicillin against Streptococcus pneumoniae as determined by three quantitative methods.

Authors:  A L Barry; S D Brown; P C Fuchs
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-04       Impact factor: 3.267

6.  Rapid detection of penicillin-resistant Streptococcus pneumoniae in cerebrospinal fluid by a seminested-PCR strategy.

Authors:  M du Plessis; A M Smith; K P Klugman
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

7.  A qualitative study of pharmacists' perceptions of, and recommendations for improvement of antibiotic use in Qatar.

Authors:  Emily Black; Andrea Cartwright; Sumaia Bakharaiba; Eman Al-Mekaty; Dima Alsahan
Journal:  Int J Clin Pharm       Date:  2014-06-05

Review 8.  Enterobacter spp.: pathogens poised to flourish at the turn of the century.

Authors:  W E Sanders; C C Sanders
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

9.  Prevalence of a putative efflux mechanism among fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae.

Authors:  N P Brenwald; M J Gill; R Wise
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

10.  Solution structure and function of an essential CMP kinase of Streptococcus pneumoniae.

Authors:  Liping Yu; Jamey Mack; Philip J Hajduk; Steve J Kakavas; Anne Y C Saiki; Claude G Lerner; Edward T Olejniczak
Journal:  Protein Sci       Date:  2003-11       Impact factor: 6.725
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.